Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

PHASE3CompletedINTERVENTIONAL
Enrollment

186

Participants

Timeline

Start Date

January 30, 2012

Primary Completion Date

December 10, 2018

Study Completion Date

December 10, 2018

Conditions
Congenital Bleeding DisorderHaemophilia A
Interventions
DRUG

turoctocog alfa pegol

Administered i.v.

Trial Locations (93)

100

Novo Nordisk Investigational Site, Taipei

500

Novo Nordisk Investigational Site, Changhua

1011

Novo Nordisk Investigational Site, Lausanne

1211

Novo Nordisk Investigational Site, Geneva

1756

Novo Nordisk Investigational Site, Sofia

2050

Novo Nordisk Investigational Site, Camperdown

2100

Novo Nordisk Investigational Site, København Ø

3052

Novo Nordisk Investigational Site, Parkville

4012

Novo Nordisk Investigational Site, Debrecen

4101

Novo Nordisk Investigational Site, South Brisbane

8091

Novo Nordisk Investigational Site, Zurich

8200

Novo Nordisk Investigational Site, Århus N

10249

Novo Nordisk Investigational Site, Berlin

19104

Novo Nordisk Investigational Site, Philadelphia

19134

Novo Nordisk Investigational Site, Philadelphia

20007

Novo Nordisk Investigational Site, Washington D.C.

20124

Novo Nordisk Investigational Site, Milan

21205

Novo Nordisk Investigational Site, Baltimore

22908

Novo Nordisk Investigational Site, Charlottesville

23507

Novo Nordisk Investigational Site, Norfolk

28046

Novo Nordisk Investigational Site, Madrid

29010

Novo Nordisk Investigational Site, Málaga

29425

Novo Nordisk Investigational Site, Charleston

30625

Novo Nordisk Investigational Site, Hanover

30912

Novo Nordisk Investigational Site, Augusta

32827

Novo Nordisk Investigational Site, Orlando

33100

Novo Nordisk Investigational Site, Udine

33607

Novo Nordisk Investigational Site, Tampa

35100

Novo Nordisk Investigational Site, Bornova-IZMIR

36100

Novo Nordisk Investigational Site, Vicenza

44093

Novo Nordisk Investigational Site, Nantes

45404

Novo Nordisk Investigational Site, Dayton

48201

Novo Nordisk Investigational Site, Detroit

48823

Novo Nordisk Investigational Site, East Lansing

50134

Novo Nordisk Investigational Site, Florence

50400

Novo Nordisk Investigational Site, Kuala Lumpur

52242

Novo Nordisk Investigational Site, Iowa City

52621

Novo Nordisk Investigational Site, Tel Litwinsky

53127

Novo Nordisk Investigational Site, Bonn

55319

Novo Nordisk Investigational Site, Samsun

55404

Novo Nordisk Investigational Site, Minneapolis

60590

Novo Nordisk Investigational Site, Frankfurt/M.

66421

Novo Nordisk Investigational Site, Homburg

68000

Novo Nordisk Investigational Site, Selangor Darul Ehsan

69677

Novo Nordisk Investigational Site, Bron

75015

Novo Nordisk Investigational Site, Paris

77030

Novo Nordisk Investigational Site, Houston

80336

Novo Nordisk Investigational Site, München

83712

Novo Nordisk Investigational Site, Boise

85016

Novo Nordisk Investigational Site, Phoenix

90806

Novo Nordisk Investigational Site, Long Beach

94270

Novo Nordisk Investigational Site, Le Kremlin-Bicêtre

95817

Novo Nordisk Investigational Site, Sacramento

97239

Novo Nordisk Investigational Site, Portland

99204

Novo Nordisk Investigational Site, Spokane

191065

Novo Nordisk Investigational Site, Saint Petersburg

452289

Novo Nordisk Investigational Site, Cincinnati

90502-2004

Novo Nordisk Investigational Site, Torrance

20010-2978

Novo Nordisk Investigational Site, Washington D.C.

70118-5720

Novo Nordisk Investigational Site, New Orleans

02115

Novo Nordisk Investigational Site, Boston

68198-5456

Novo Nordisk Investigational Site, Omaha

08901

Novo Nordisk Investigational Site, New Brunswick

07102

Novo Nordisk Investigational Site, Newark

37232-9830

Novo Nordisk Investigational Site, Nashville

13081-970

Novo Nordisk Investigational Site, Campinas

21 000

Novo Nordisk Investigational Site, Split

10 000

Novo Nordisk Investigational Site, Zagreb

H-1134

Novo Nordisk Investigational Site, Budapest

466-8560

Novo Nordisk Investigational Site, Aichi

734-8551

Novo Nordisk Investigational Site, Hiroshima

807 8555

Novo Nordisk Investigational Site, Kitakyusyu, Fukuoka

634-8522

Novo Nordisk Investigational Site, Nara

350-0225

Novo Nordisk Investigational Site, Saitama

329 0498

Novo Nordisk Investigational Site, Shimotsuke-shi, Tochigi

420-8660

Novo Nordisk Investigational Site, Shizuoka

108-8639

Novo Nordisk Investigational Site, Tokyo

160-0023

Novo Nordisk Investigational Site, Tokyo

167-0035

Novo Nordisk Investigational Site, Tokyo

241-0811

Novo Nordisk Investigational Site, Yokohama-shi, Kanagawa

9713 GZ

Novo Nordisk Investigational Site, Groningen

3015 CE

Novo Nordisk Investigational Site, Rotterdam

0027

Novo Nordisk Investigational Site, Oslo

00935

Novo Nordisk Investigational Site, San Juan

302-799

Novo Nordisk Investigational Site, Daejeon

205 02

Novo Nordisk Investigational Site, Malmo

01130

Novo Nordisk Investigational Site, Adana

RG24 9NA

Novo Nordisk Investigational Site, Basingstoke

CF14 4XW

Novo Nordisk Investigational Site, Cardiff

NW3 2QG

Novo Nordisk Investigational Site, London

SE1 7EH

Novo Nordisk Investigational Site, London

OX3 7LJ

Novo Nordisk Investigational Site, Oxford

S10 2JF

Novo Nordisk Investigational Site, Sheffield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY